Reviewed by the PeptideMind Team · Updated July 19, 2026
BPC-157 vs TB-500:
The Wolverine peptide stack comparison
BPC-157 acts locally at the site of injury. TB-500 acts systemically through the bloodstream. Here is how bpc 157 and tb 500 compare, and why they're often combined into the Wolverine Stack.
As seen on
What Is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic, stable peptide fragment based on a protein found in human gastric juice, studied for its role in localized tissue repair.
Localized mechanism
A stable, synthetic fragment derived from human gastric juice, studied for angiogenesis and growth-factor activity at the site of an injury.
Best-studied use case
Gastrointestinal healing plus tendon and ligament research, where a concentrated, site-specific effect is the priority.
Research status
Not FDA-approved for human use and banned by WADA since 2022. Sold strictly for research purposes.
What Is TB-500?
TB-500 is a synthetic version of a fragment of Thymosin Beta-4, a protein that occurs naturally throughout the body, studied for its role in systemic recovery.
Systemic mechanism
A synthetic fragment of Thymosin Beta-4, studied for regulating actin, the protein that drives cell migration and blood vessel formation.
Best-studied use case
Wound healing and angiogenesis research where a whole-body, circulating effect is the priority, rather than one localized area.
Research status
Not FDA-approved for human use and banned by WADA since 2022. Sold strictly for research purposes.
BPC-157 vs TB-500 at a Glance
A feature-by-feature look at how bpc 157 and tb 500 differ across mechanism, dosing, and legal status.
Overview
- Type
- Single peptide
- Primary category
- Healing
- Secondary categories
- Longevity
- Research status
- Preclinical
- FDA approved
- Not FDA approved
- Popularity
- 10/10
- Body targets
- GutMuscleJoints & Bone
- Price range
- $29.99 – $320.00
- Human trial status
- Human pilot studies
- Legal status
- Research chemical
- WADA status
- Banned
Dosing
- Dose
- 250–500 mcg
- Frequency
- Daily
- Cycle
- As needed
- Route of administration
- Subcutaneous
- Common vial sizes
- 5mg10mg
Research
- Molecular weight
- 1419.54 g/mol
- Half-life
- 0.5 hrs
- Median onset
- —
- Prescription alternative
- No alternative
- Receptor target
- VEGFRGHR
- Receptor action
- Modulator
- Mechanistic pathways
- VEGF AngiogenesisGastric CytoprotectiveGHRH GH AXIS
Overview
- Type
- Single peptide
- Primary category
- Healing
- Secondary categories
- Longevity
- Research status
- Preclinical
- FDA approved
- Not FDA approved
- Popularity
- 9/10
- Body targets
- MuscleHeartJoints & Bone
- Price range
- $34.00 – $332.00
- Human trial status
- Human RCTs
- Legal status
- Research chemical
- WADA status
- Banned
Dosing
- Dose
- 1–2 mg
- Frequency
- 2x/week
- Cycle
- 4–6 weeks
- Route of administration
- Subcutaneous
- Common vial sizes
- 2mg5mg+1
Research
- Molecular weight
- 889.02 g/mol
- Half-life
- 2 hrs
- Median onset
- —
- Prescription alternative
- No alternative
- Receptor target
- —
- Receptor action
- Modulator
- Mechanistic pathways
- VEGF AngiogenesisImmune ModulatingActin Cytoskeleton Regulation
Our top-rated vendor
Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing, no paid placements, no affiliate influence. We update this list as new data comes in.
Based on current scores, this vendor ranks highest across those criteria.
Comparison at a Glance: BPC-157 vs TB-500
A quick side-by-side look at how bpc 157 and tb 500 differ across mechanism, dosing, cycle length, and legal status.
Site of action
BPC-157 concentrates its effect at the local site of injury. TB-500 circulates systemically through the bloodstream.
Typical research dose
BPC-157 is commonly dosed at 200 to 500 mcg per day. TB-500 is commonly dosed at 2 to 5 mg per week.
Typical cycle length
BPC-157 protocols often run 4 to 6 weeks. TB-500 protocols often run 4 to 8 weeks, then reassess.
Legal and administration
Neither is FDA-approved for human use; both are WADA-banned. Both are most commonly injected subcutaneously in research use.
Wolverine Blend Dosage Guide for Recovery & RepairWolverine Blend Dosage Calculator
This combines BPC-157 and TB-500, two well-known healing peptides, to speed up tissue recovery from injuries. Doses are listed per peptide, so a 500 mcg dose means 500 mcg of each, or 1 mg total.
Vial size
20 mg
Bacteriostatic water
2 mL
Dosing
250–500 mcg each
Frequency
Daily
Cycle
4–8 weeks
Benefit
Recovery & Repair
Why It's Called the Wolverine Stack
BPC-157 and TB-500 are frequently combined into what researchers nickname the Wolverine Stack, pairing a localized healer with a systemic one in a single protocol.
A nod to rapid regeneration
The pairing earned the nickname Wolverine Stack as a reference to the Marvel character's rapid regenerative healing, not a scientific or regulatory term.
Local plus systemic
BPC-157 concentrates at the injury site while TB-500 supports recovery throughout the body at the same time, which is why the two are combined rather than used alone.
Not an approved treatment
The Wolverine Stack is a research and discussion term, not a clinical protocol. Neither compound is FDA-approved for human use.
Frequently Asked Questions: BPC-157 vs TB-500
Straight answers on how BPC-157 and TB-500 compare, how the Wolverine Stack works, and how to dose the blend. For research reference only.
Stacking BPC-157 and TB-500: Dosing Basics
Most research write-ups anchor the blend to BPC-157, dosed daily, and layer TB-500 on a less frequent schedule since it acts more systemically and builds up over a longer window.
Anchor to BPC-157
Most protocols dose BPC-157 daily and calculate the TB-500 volume against that same draw, rather than dosing each peptide on a separate schedule.
Fixed blend ratio
In a combined vial, the ratio between BPC-157 and TB-500 is fixed at manufacture, so the water volume you add changes both concentrations at once.
Use a blend-specific calculator
A single-peptide calculator will not account for a fixed-ratio blend. Use a blend dosage calculator to get an accurate draw volume for both compounds.
Recovery Timeline: What to Expect Week by Week
Timelines vary by individual, injury type, and protocol, but many research write-ups describe a similar general pattern.
Weeks 1 to 2
Research write-ups commonly describe an early reduction in localized pain and inflammation as BPC-157's effect at the injury site takes hold.
Weeks 4 to 8
This window is typically associated with the bulk of structural tissue healing, as both peptides continue supporting the repair process.
Weeks 8 to 12
Many protocols describe a fuller recovery by this stage, with cycles concluding or moving into a maintenance and reassessment phase.
Other Comparisons
Weight
GLP-2
Metabolic
Weight
GLP-1
Metabolic
Tirzepatide vs Semaglutide: Key differences comparison
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1). Semaglutide activates only GLP-1. Here's how tirzepatide and semaglutide compare on weight loss, side effects, cost, and safety.
Healing
Klow
Skin
Skin
Glow
Healing
Klow vs Glow: Key differences comparison
Klow and Glow share the same GHK-Cu, BPC-157, and TB-500 base. Klow adds a fourth peptide, KPV, for extra anti-inflammatory and immune support. Here's how Klow and Glow compare.
Skin
MT-1
Skin
Skin
MT-2
Sexual
Melanotan 1 vs Melanotan 2: Key differences comparison
Melanotan I is selective for MC1R and stays focused on pigment. Melanotan II activates multiple melanocortin receptors, driving broader effects on appetite and sexual response. Here's how MT-1 and MT-2 compare.